Posts Tagged ‘gilead’

A pharmaceutical company that has in recent years made billions of dollars on hepatitis C treatments—the three the FDA has approved range from $75,000 to $94,500—has been named a “price gouger” and “tax dodger” in a new report. Gilead Sciences, the sixth richest drugmaker in the world, “is making a fortune selling essential drugs to…